From sourcing and supply through joint ventures and market access — here's how Apollo works with manufacturers, buyers, and investors.
A qualified, regulatory-aware route into new markets — with a partner who has skin in the game and manufactures on the ground.
Supplier qualification, audit, negotiation, and follow-through in China — handled by a Chinese counterparty, not a one-time trader.
Data-backed market intelligence on healthcare and pharmaceutical opportunities, drawn from Apollo's own trade-record analysis.
Sourcing, qualification, and supply of active pharmaceutical ingredients, key starting materials, excipients, and finished dosage forms — with supplier audits, documentation review, and regulatory support for import.
Structuring and executing ToT and JV arrangements between Chinese manufacturers and partners abroad — from product selection and feasibility through line setup, validation, and launch.
Tender identification, bid preparation, and delivery for public-sector healthcare procurement, with qualified Chinese manufacturers as principals and Apollo as the counterparty.
Diagnostic, imaging, and critical-care equipment, plus medical consumables — delivered in partnership with our China-based network.
Utility systems, HVAC, backup power, vertical mobility, and hospital digitalisation for new and upgraded facilities.
For manufacturers: market assessment, distributor selection, pricing strategy, regulatory pathway, and ongoing representation in target markets.
Data-backed market intelligence on high-growth healthcare and pharmaceutical opportunities, starting with our Pakistan healthcare market analysis.
Our first market report maps the healthcare services, medical device, and pharmaceutical landscape in Pakistan for Chinese investors and partners — built on public data and Apollo's own proprietary trade-record analysis.
Pakistan Healthcare — Market Report
Request the report